Medigen gets funds from global foundation for mix-and-match booster trials
12/02/2021 10:51 PM
Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Formosa Smart Energy partners with Polish group on new energy projects
07/02/2025 03:16 PM - Business
Taipei Fubon Bank secures FSC approval to open branch in India
07/02/2025 03:05 PM - Politics
Senior KMT official detained in Pingtung recall forgery case
07/02/2025 02:01 PM - Business
Taiwan shares close up 0.11%
07/02/2025 01:54 PM - Business
Stock trading accounts hit new high despite U.S. tariff concerns
07/02/2025 12:47 PM